Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Patients with ankylosing spondylitis present a distinct CD8 T cell subset with osteogenic and cytotoxic potential
RMD Open, 23 febbraio 2024

2) The interplay between previous infection and mental health condition on antibody response to COVID-19 mRNA vaccination
Brain _ Behavior _ & Immunity Health, 25 agosto 2023

3) The chemokine landscape: one system multiple shades
Frontiers in Immunology, 11 maggio 2023

4) Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course
Nature Immunology, 6 marzo 2023

5) Tracking unlabeled cancer cells imaged with low resolution in wide migration chambers via U-NET class-1 probability (pseudofluorescence)
Journal of Biological Engineering, 24 gennaio 2023

6) Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2
bioRxiv, 28 novembre 2022

7) Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19
Nature Immunology, 27 maggio 2022

8) Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
bioRxiv, 23 maggio 2022

9) Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
Nature Immunology, febbraio 2022

10) Basal and IL-1β enhanced chondrocyte chemotactic activity on monocytes are co-dependent on both IKKα and IKKβ NF-κB activating kinases
Scientific Reports, 4 novembre 2021

11) Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction
Journal of Medical Chemistry, 23 settembre 2021

12) HMGB1 promotes CXCL12-dependent egress of murine B cells from Peyer’s patches in homeostasis
European Journal of Immunology, 1 giugno 2021

13) Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland
The Lancet Regional Health - Europe, febbraio 2021

14) β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4
Frontiers in Immunology, 18 settembre 2020

15) B cell zone reticular cell microenvironments shape CXCL13 gradient formation
Nature Communications, 22 luglio 2020

16) ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins
Frontiers in Immunology, 22 aprile 2020
Mariagrazia Uguccioni
is currently collaborating with
Istituto di Ricerca in Biomedicina (IRB) (Rif. IRB)
Via Francesco Chiesa 5
6500 Bellinzona
Mariagrazia Uguccioni
on behalf of
Istituto di Ricerca in Biomedicina (IRB) USI (Rif. IRB)
is currently participating in the Research Group
Chemokine ed Immunità
as Group Leader [Rif. 55110]